These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 5595260)
21. Mutation of the Myxoma virus SERP2 P1-site to prevent proteinase inhibition causes apoptosis in cultured RK-13 cells and attenuates disease in rabbits, but mutation to alter specificity causes apoptosis without reducing virulence. MacNeill AL; Turner PC; Moyer RW Virology; 2006 Dec 5-20; 356(1-2):12-22. PubMed ID: 16959285 [TBL] [Abstract][Full Text] [Related]
22. [Myxomatosis in the sub-antarctic islands of Kerguelen, without vectors, thirty years after its introduction]. Chapuis JL; Chantal J; Bijlenga G C R Acad Sci III; 1994 Feb; 317(2):174-82. PubMed ID: 7994607 [TBL] [Abstract][Full Text] [Related]
23. Control of rabbit myxomatosis in Poland. Górski J; Mizak B; Chrobocińska M Rev Sci Tech; 1994 Sep; 13(3):869-79. PubMed ID: 7949359 [TBL] [Abstract][Full Text] [Related]
24. The differential transmissibility of Myxoma virus strains of differing virulence grades by the rabbit flea Spilopsyllus cuniculi (Dale). Mead-Briggs AR; Vaughan JA J Hyg (Lond); 1975 Oct; 75(2):237-47. PubMed ID: 1058245 [TBL] [Abstract][Full Text] [Related]
25. Vaccination of free-living juvenile wild rabbits (Oryctolagus cuniculus) against myxomatosis improved their survival. Guitton JS; Devillard S; Guénézan M; Fouchet D; Pontier D; Marchandeau S Prev Vet Med; 2008 Apr; 84(1-2):1-10. PubMed ID: 18045714 [TBL] [Abstract][Full Text] [Related]
26. Limitations of plasmid vaccines to complex viruses: selected myxoma virus antigens as DNA vaccines were not protective. Adams MM; van Leeuwen BH; Kerr PJ Vaccine; 2004 Nov; 23(2):198-204. PubMed ID: 15531037 [TBL] [Abstract][Full Text] [Related]
27. Myxomatosis. The effect of age upon survival of wild and domestic rabbits (Oryctolagus cuniculus) with a degree of genetic resistance and unselected domestic rabbits infected with myxoma virus. Sobey WR; Conolly D; Haycockp ; Edmonds JW J Hyg (Lond); 1970 Mar; 68(1):137-49. PubMed ID: 5267123 [TBL] [Abstract][Full Text] [Related]
28. Role of the C-terminal RDEL motif of the myxoma virus M-T4 protein in terms of apoptosis regulation and viral pathogenesis. Hnatiuk S; Barry M; Zeng W; Liu L; Lucas A; Percy D; McFadden G Virology; 1999 Oct; 263(2):290-306. PubMed ID: 10544103 [TBL] [Abstract][Full Text] [Related]
29. Selection for resistance to myxomatosis in domestic rabbits (Oryctolagus cuniculus). Sobey WR J Hyg (Lond); 1969 Dec; 67(4):743-54. PubMed ID: 5261215 [No Abstract] [Full Text] [Related]
30. Myxoma virus M063R is a host range gene essential for virus replication in rabbit cells. Barrett JW; Shun Chang C; Wang G; Werden SJ; Shao Z; Barrett C; Gao X; Belsito TA; Villenevue D; McFadden G Virology; 2007 Apr; 361(1):123-32. PubMed ID: 17184804 [TBL] [Abstract][Full Text] [Related]
32. Isolation of an attenuated myxoma virus field strain that can confer protection against myxomatosis on contacts of vaccinates. Bárcena J; Pagès-Manté A; March R; Morales M; Ramírez MA; Sánchez-Vizcaíno JM; Torres JM Arch Virol; 2000; 145(4):759-71. PubMed ID: 10893154 [TBL] [Abstract][Full Text] [Related]
33. Myxoma virus M130R is a novel virulence factor required for lethal myxomatosis in rabbits. Barrett JW; Werden SJ; Wang F; McKillop WM; Jimenez J; Villeneuve D; McFadden G; Dekaban GA Virus Res; 2009 Sep; 144(1-2):258-65. PubMed ID: 19477207 [TBL] [Abstract][Full Text] [Related]
34. The myxoma virus M-T4 gene encodes a novel RDEL-containing protein that is retained within the endoplasmic reticulum and is important for the productive infection of lymphocytes. Barry M; Hnatiuk S; Mossman K; Lee SF; Boshkov L; McFadden G Virology; 1997 Dec; 239(2):360-77. PubMed ID: 9434727 [TBL] [Abstract][Full Text] [Related]
35. Sequence mapping of the Californian MSW strain of Myxoma virus. Labudovic A; Perkins H; van Leeuwen B; Kerr P Arch Virol; 2004 Mar; 149(3):553-70. PubMed ID: 14991443 [TBL] [Abstract][Full Text] [Related]
36. ATTENUATION OF THE MYXOMA VIRUS AND USE OF THE LIVING ATTENUATED VIRUS AS AN IMMUNIZING AGENT FOR MYXOMATOSIS. SAITO JK; MCKERCHER DG; CASTRUCCI G J Infect Dis; 1964 Dec; 114():417-28. PubMed ID: 14233132 [No Abstract] [Full Text] [Related]
37. Atypical myxomatosis--virus isolation, experimental infection of rabbits and restriction endonuclease analysis of the isolate. Psikal I; Smíd B; Rodák L; Valícek L; Bendová J J Vet Med B Infect Dis Vet Public Health; 2003 Aug; 50(6):259-64. PubMed ID: 14628995 [TBL] [Abstract][Full Text] [Related]
38. Changes in the virulence of myxoma virus strains in Britain. Ross J; Sanders MF Epidemiol Infect; 1987 Feb; 98(1):113-7. PubMed ID: 3556434 [TBL] [Abstract][Full Text] [Related]
39. Viral skin diseases of the rabbit. Meredith AL Vet Clin North Am Exot Anim Pract; 2013 Sep; 16(3):705-14. PubMed ID: 24018033 [TBL] [Abstract][Full Text] [Related]
40. Construction and testing of a novel host-range defective myxoma virus vaccine with the M063 gene inactivated that is non-permissive for replication in rabbit cells. Adams MM; van Leeuwen BH; McFadden G; Kerr PJ Vet Res; 2008; 39(6):60. PubMed ID: 18778680 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]